CN Stock MarketDetailed Quotes

688578 Shanghai Allist Pharmaceuticals Co., Ltd.

Watchlist
  • 43.88
  • -1.73-3.79%
Market Closed Sep 13 15:00 CST
19.75BMarket Cap18.09P/E (TTM)

Shanghai Allist Pharmaceuticals Co., Ltd. Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Assets
Current assets
Money funds
-29.20%462.94M
347.22%2.4B
295.79%1.86B
46.35%1.47B
-35.92%653.87M
-21.64%536.12M
-23.54%470.49M
3.99%1B
82.69%1.02B
-1.42%684.15M
Transactional financial assets
66.78%2.34B
-80.86%277.68M
-73.22%419.6M
-16.26%786.01M
37.99%1.4B
0.83%1.45B
-3.56%1.57B
-41.91%938.58M
-45.74%1.02B
-19.62%1.44B
Notes receivable and accounts receivable
44.50%317.99M
34.67%271.25M
72.47%260.17M
86.48%216.01M
186.67%220.07M
403.01%201.42M
917.09%150.85M
198.28%115.84M
66.82%76.77M
7.20%40.04M
-Accounts receivable
44.50%317.99M
34.67%271.25M
72.47%260.17M
86.48%216.01M
186.67%220.07M
403.01%201.42M
917.09%150.85M
198.28%115.84M
66.82%76.77M
7.20%40.04M
Other receivables (including interest and dividends)
-78.97%2.87M
-27.70%6.24M
-24.28%5.17M
60.51%15.06M
286.42%13.64M
160.92%8.63M
230.71%6.82M
82.84%9.38M
17.56%3.53M
20.80%3.31M
-Other receivable
-78.97%2.87M
----
-24.28%5.17M
----
286.42%13.64M
----
230.71%6.82M
----
57.43%3.53M
----
Advance payment
20.42%35.95M
-51.57%15.89M
-26.91%34.29M
-21.40%27.92M
1.44%29.85M
-32.66%32.82M
28.39%46.92M
2.69%35.52M
-4.07%29.43M
197.78%48.73M
Inventories
-30.87%39.2M
12.92%46.12M
96.27%62.95M
156.41%60.19M
133.68%56.7M
86.91%40.85M
54.22%32.07M
5.47%23.48M
32.01%24.26M
52.50%21.85M
Non-current assets due within one year
-37.01%160.87M
1,506.15%93.12M
4,355.26%258.31M
786.68%257.54M
785.08%255.38M
-79.28%5.8M
-79.40%5.8M
--29.05M
--28.85M
--27.99M
Other current assets
18.51%9.1M
71.31%7.33M
-18.69%5.27M
51.76%3.89M
78.64%7.68M
-83.98%4.28M
-79.91%6.48M
-91.60%2.56M
-82.63%4.3M
-6.15%26.69M
Total current assets
27.64%3.37B
36.59%3.12B
27.19%2.91B
31.39%2.84B
19.79%2.64B
-0.47%2.28B
-3.72%2.29B
-20.43%2.16B
-13.76%2.21B
-11.29%2.29B
Non Current assets
Other equity investment
208.43%168.72M
210.87%161.72M
175.50%145.26M
27.22%54.36M
35.45%54.7M
36.18%52.02M
37.43%52.73M
21.68%42.72M
--40.39M
--38.2M
Fixed assets
-6.91%492.22M
----
-3.42%505.98M
----
319.89%528.75M
----
298.41%523.91M
----
-1.02%125.93M
----
Constru in process
520.76%27.91M
----
34.67%18.58M
----
-98.44%4.5M
----
-94.82%13.8M
----
83.46%288.84M
----
Intangible assets
-2.19%65.98M
-2.88%66M
-2.86%66.49M
-2.53%66.99M
1.22%67.46M
1.62%67.95M
1.72%68.45M
0.35%68.73M
-3.03%66.64M
-2.76%66.87M
Development expenditure
----
----
----
--19.06M
--19.06M
--19.06M
----
----
----
----
Long deferred expense
-12.09%495.18K
18.65%691.73K
23.93%710.89K
-3.71%781.29K
-57.60%563.31K
-65.84%583.02K
-72.78%573.64K
-68.60%811.41K
-54.15%1.33M
-48.53%1.71M
Deferred tax assets
----
----
----
--6.88M
--7.41M
--11.5M
--11.5M
----
----
----
Usufruct assets
-38.21%1.7M
-35.85%1.89M
-6.94%2.08M
-17.03%2.42M
-16.50%2.75M
-22.10%2.95M
-62.59%2.23M
-65.21%2.92M
-69.50%3.29M
-69.78%3.79M
Other non current assets
122.84%825.71M
72.13%833.28M
51.11%729.5M
-7.35%456.65M
-11.60%370.55M
85.22%484.11M
98.02%482.76M
1,630.10%492.85M
1,381.36%419.16M
829.96%261.38M
Total non current assets
49.92%1.58B
34.73%1.59B
27.05%1.47B
8.33%1.14B
11.65%1.06B
50.95%1.18B
52.99%1.16B
129.00%1.05B
139.17%945.57M
109.78%779.5M
Total assets
34.00%4.95B
35.95%4.7B
27.14%4.38B
23.84%3.97B
17.35%3.7B
12.58%3.46B
9.96%3.44B
1.20%3.21B
6.72%3.15B
3.93%3.07B
Liabilities
Current liabilities
Notes payable and accounts payable
-6.85%29.69M
-21.68%31.73M
22.36%53.46M
5.35%24.44M
21.90%31.88M
-22.82%40.52M
35.23%43.69M
-32.04%23.2M
-17.79%26.15M
114.07%52.5M
-Accounts payable
-6.85%29.69M
-21.68%31.73M
22.36%53.46M
5.35%24.44M
21.90%31.88M
-22.82%40.52M
35.23%43.69M
-32.04%23.2M
-17.79%26.15M
114.07%52.5M
Contract liabilities
----
----
----
----
-4.61%253.4K
----
-40.72%104.77K
--13.49K
--265.63K
--330.45K
Salaries payable
58.99%118.49M
114.26%111.25M
91.59%124.61M
86.40%95.76M
83.90%74.53M
94.11%51.92M
57.30%65.04M
36.89%51.38M
43.30%40.53M
23.18%26.75M
Taxs payable
166.31%79.18M
70.14%45.48M
26.64%42.59M
300.50%35.68M
228.74%29.73M
2,195.67%26.73M
645.42%33.63M
9.61%8.91M
126.18%9.04M
-63.11%1.16M
Other payable (including interest and dividends)
49.93%194.4M
85.42%183.49M
51.03%166.88M
367.22%170.13M
271.33%129.66M
420.57%98.96M
51.24%110.5M
132.74%36.41M
-15.73%34.92M
-54.65%19.01M
-Other payable
49.93%194.4M
----
51.03%166.88M
----
271.33%129.66M
----
51.24%110.5M
----
-15.73%34.92M
----
Non current liabilities due within one year
204.18%1.04M
--1.27M
-13.60%1.43M
-72.43%479.55K
-84.80%343.22K
----
-64.90%1.66M
--1.74M
--2.26M
--2.67M
Total current liabilities
58.72%422.81M
71.10%373.22M
53.18%390.03M
168.39%326.5M
135.41%266.39M
112.98%218.13M
63.09%254.62M
27.43%121.65M
7.24%113.16M
12.16%102.42M
Current liabilities
Estimate liabilities
0.00%107.01K
-45.79%107.01K
-45.79%107.01K
-45.79%107.01K
-45.79%107.01K
0.00%197.41K
0.00%197.41K
0.00%197.41K
0.00%197.41K
26.37%197.41K
Deferred tax liabilities
--15.42M
--2.61M
--142.26K
----
----
----
----
----
----
----
Lease liabilities
-87.60%265.54K
-90.58%233.9K
30.81%393.22K
225.71%1.59M
1,421.12%2.14M
1,021.24%2.48M
-55.71%300.6K
-92.48%486.66K
-98.41%140.75K
-97.98%221.48K
Other non current liabilities
--3.54M
--3.54M
--3.54M
----
----
----
----
----
----
----
Total non current liabilities
759.99%19.33M
142.31%6.5M
740.54%4.19M
147.36%1.69M
564.77%2.25M
539.97%2.68M
-43.16%498.01K
-89.74%684.07K
-96.27%338.16K
-96.23%418.89K
Total liabilities
64.59%442.14M
71.96%379.72M
54.52%394.22M
168.27%328.19M
136.69%268.64M
114.72%220.81M
62.50%255.12M
19.78%122.33M
-0.96%113.5M
0.40%102.84M
Shareholders equity
Paid-in capital
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
0.00%450M
Capital reserve funds
2.48%3.21B
2.51%3.19B
2.42%3.17B
1.96%3.15B
2.12%3.13B
2.18%3.11B
2.27%3.1B
2.43%3.09B
2.37%3.07B
2.45%3.05B
Surplus reserve funds
--91.68M
--61.67M
--34.99M
----
----
----
----
----
----
----
Retained profit
477.59%648.48M
247.24%508.4M
160.25%229.03M
106.63%30.27M
64.51%-171.74M
35.26%-345.28M
25.56%-380.16M
-15.91%-456.74M
20.32%-483.91M
6.96%-533.35M
Other composite income
479.71%113.57M
536.43%107.62M
431.57%93.63M
152.82%19.24M
271.47%19.59M
447.57%16.91M
441.34%17.61M
--7.61M
--5.27M
--3.09M
Shareholders equity without minority interests
31.61%4.51B
33.50%4.32B
24.95%3.98B
18.11%3.65B
12.89%3.43B
9.04%3.24B
7.19%3.19B
0.59%3.09B
7.03%3.04B
4.06%2.97B
Total shareholder equity
31.61%4.51B
33.50%4.32B
24.95%3.98B
18.11%3.65B
12.89%3.43B
9.04%3.24B
7.19%3.19B
0.59%3.09B
7.03%3.04B
4.06%2.97B
Total liabilityies and equity
34.00%4.95B
35.95%4.7B
27.14%4.38B
23.84%3.97B
17.35%3.7B
12.58%3.46B
9.96%3.44B
1.20%3.21B
6.72%3.15B
3.93%3.07B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Assets
Current assets
Money funds -29.20%462.94M347.22%2.4B295.79%1.86B46.35%1.47B-35.92%653.87M-21.64%536.12M-23.54%470.49M3.99%1B82.69%1.02B-1.42%684.15M
Transactional financial assets 66.78%2.34B-80.86%277.68M-73.22%419.6M-16.26%786.01M37.99%1.4B0.83%1.45B-3.56%1.57B-41.91%938.58M-45.74%1.02B-19.62%1.44B
Notes receivable and accounts receivable 44.50%317.99M34.67%271.25M72.47%260.17M86.48%216.01M186.67%220.07M403.01%201.42M917.09%150.85M198.28%115.84M66.82%76.77M7.20%40.04M
-Accounts receivable 44.50%317.99M34.67%271.25M72.47%260.17M86.48%216.01M186.67%220.07M403.01%201.42M917.09%150.85M198.28%115.84M66.82%76.77M7.20%40.04M
Other receivables (including interest and dividends) -78.97%2.87M-27.70%6.24M-24.28%5.17M60.51%15.06M286.42%13.64M160.92%8.63M230.71%6.82M82.84%9.38M17.56%3.53M20.80%3.31M
-Other receivable -78.97%2.87M-----24.28%5.17M----286.42%13.64M----230.71%6.82M----57.43%3.53M----
Advance payment 20.42%35.95M-51.57%15.89M-26.91%34.29M-21.40%27.92M1.44%29.85M-32.66%32.82M28.39%46.92M2.69%35.52M-4.07%29.43M197.78%48.73M
Inventories -30.87%39.2M12.92%46.12M96.27%62.95M156.41%60.19M133.68%56.7M86.91%40.85M54.22%32.07M5.47%23.48M32.01%24.26M52.50%21.85M
Non-current assets due within one year -37.01%160.87M1,506.15%93.12M4,355.26%258.31M786.68%257.54M785.08%255.38M-79.28%5.8M-79.40%5.8M--29.05M--28.85M--27.99M
Other current assets 18.51%9.1M71.31%7.33M-18.69%5.27M51.76%3.89M78.64%7.68M-83.98%4.28M-79.91%6.48M-91.60%2.56M-82.63%4.3M-6.15%26.69M
Total current assets 27.64%3.37B36.59%3.12B27.19%2.91B31.39%2.84B19.79%2.64B-0.47%2.28B-3.72%2.29B-20.43%2.16B-13.76%2.21B-11.29%2.29B
Non Current assets
Other equity investment 208.43%168.72M210.87%161.72M175.50%145.26M27.22%54.36M35.45%54.7M36.18%52.02M37.43%52.73M21.68%42.72M--40.39M--38.2M
Fixed assets -6.91%492.22M-----3.42%505.98M----319.89%528.75M----298.41%523.91M-----1.02%125.93M----
Constru in process 520.76%27.91M----34.67%18.58M-----98.44%4.5M-----94.82%13.8M----83.46%288.84M----
Intangible assets -2.19%65.98M-2.88%66M-2.86%66.49M-2.53%66.99M1.22%67.46M1.62%67.95M1.72%68.45M0.35%68.73M-3.03%66.64M-2.76%66.87M
Development expenditure --------------19.06M--19.06M--19.06M----------------
Long deferred expense -12.09%495.18K18.65%691.73K23.93%710.89K-3.71%781.29K-57.60%563.31K-65.84%583.02K-72.78%573.64K-68.60%811.41K-54.15%1.33M-48.53%1.71M
Deferred tax assets --------------6.88M--7.41M--11.5M--11.5M------------
Usufruct assets -38.21%1.7M-35.85%1.89M-6.94%2.08M-17.03%2.42M-16.50%2.75M-22.10%2.95M-62.59%2.23M-65.21%2.92M-69.50%3.29M-69.78%3.79M
Other non current assets 122.84%825.71M72.13%833.28M51.11%729.5M-7.35%456.65M-11.60%370.55M85.22%484.11M98.02%482.76M1,630.10%492.85M1,381.36%419.16M829.96%261.38M
Total non current assets 49.92%1.58B34.73%1.59B27.05%1.47B8.33%1.14B11.65%1.06B50.95%1.18B52.99%1.16B129.00%1.05B139.17%945.57M109.78%779.5M
Total assets 34.00%4.95B35.95%4.7B27.14%4.38B23.84%3.97B17.35%3.7B12.58%3.46B9.96%3.44B1.20%3.21B6.72%3.15B3.93%3.07B
Liabilities
Current liabilities
Notes payable and accounts payable -6.85%29.69M-21.68%31.73M22.36%53.46M5.35%24.44M21.90%31.88M-22.82%40.52M35.23%43.69M-32.04%23.2M-17.79%26.15M114.07%52.5M
-Accounts payable -6.85%29.69M-21.68%31.73M22.36%53.46M5.35%24.44M21.90%31.88M-22.82%40.52M35.23%43.69M-32.04%23.2M-17.79%26.15M114.07%52.5M
Contract liabilities -----------------4.61%253.4K-----40.72%104.77K--13.49K--265.63K--330.45K
Salaries payable 58.99%118.49M114.26%111.25M91.59%124.61M86.40%95.76M83.90%74.53M94.11%51.92M57.30%65.04M36.89%51.38M43.30%40.53M23.18%26.75M
Taxs payable 166.31%79.18M70.14%45.48M26.64%42.59M300.50%35.68M228.74%29.73M2,195.67%26.73M645.42%33.63M9.61%8.91M126.18%9.04M-63.11%1.16M
Other payable (including interest and dividends) 49.93%194.4M85.42%183.49M51.03%166.88M367.22%170.13M271.33%129.66M420.57%98.96M51.24%110.5M132.74%36.41M-15.73%34.92M-54.65%19.01M
-Other payable 49.93%194.4M----51.03%166.88M----271.33%129.66M----51.24%110.5M-----15.73%34.92M----
Non current liabilities due within one year 204.18%1.04M--1.27M-13.60%1.43M-72.43%479.55K-84.80%343.22K-----64.90%1.66M--1.74M--2.26M--2.67M
Total current liabilities 58.72%422.81M71.10%373.22M53.18%390.03M168.39%326.5M135.41%266.39M112.98%218.13M63.09%254.62M27.43%121.65M7.24%113.16M12.16%102.42M
Current liabilities
Estimate liabilities 0.00%107.01K-45.79%107.01K-45.79%107.01K-45.79%107.01K-45.79%107.01K0.00%197.41K0.00%197.41K0.00%197.41K0.00%197.41K26.37%197.41K
Deferred tax liabilities --15.42M--2.61M--142.26K----------------------------
Lease liabilities -87.60%265.54K-90.58%233.9K30.81%393.22K225.71%1.59M1,421.12%2.14M1,021.24%2.48M-55.71%300.6K-92.48%486.66K-98.41%140.75K-97.98%221.48K
Other non current liabilities --3.54M--3.54M--3.54M----------------------------
Total non current liabilities 759.99%19.33M142.31%6.5M740.54%4.19M147.36%1.69M564.77%2.25M539.97%2.68M-43.16%498.01K-89.74%684.07K-96.27%338.16K-96.23%418.89K
Total liabilities 64.59%442.14M71.96%379.72M54.52%394.22M168.27%328.19M136.69%268.64M114.72%220.81M62.50%255.12M19.78%122.33M-0.96%113.5M0.40%102.84M
Shareholders equity
Paid-in capital 0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M0.00%450M
Capital reserve funds 2.48%3.21B2.51%3.19B2.42%3.17B1.96%3.15B2.12%3.13B2.18%3.11B2.27%3.1B2.43%3.09B2.37%3.07B2.45%3.05B
Surplus reserve funds --91.68M--61.67M--34.99M----------------------------
Retained profit 477.59%648.48M247.24%508.4M160.25%229.03M106.63%30.27M64.51%-171.74M35.26%-345.28M25.56%-380.16M-15.91%-456.74M20.32%-483.91M6.96%-533.35M
Other composite income 479.71%113.57M536.43%107.62M431.57%93.63M152.82%19.24M271.47%19.59M447.57%16.91M441.34%17.61M--7.61M--5.27M--3.09M
Shareholders equity without minority interests 31.61%4.51B33.50%4.32B24.95%3.98B18.11%3.65B12.89%3.43B9.04%3.24B7.19%3.19B0.59%3.09B7.03%3.04B4.06%2.97B
Total shareholder equity 31.61%4.51B33.50%4.32B24.95%3.98B18.11%3.65B12.89%3.43B9.04%3.24B7.19%3.19B0.59%3.09B7.03%3.04B4.06%2.97B
Total liabilityies and equity 34.00%4.95B35.95%4.7B27.14%4.38B23.84%3.97B17.35%3.7B12.58%3.46B9.96%3.44B1.20%3.21B6.72%3.15B3.93%3.07B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data